https://ift.tt/2IVHF6y
Used in the treatment of type 2 diabetes, Zomelis comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors.
from Markets https://ift.tt/2LlDC2v
from Markets https://ift.tt/2LlDC2v
MPL accuses ASCI of 'tampering' with ads
Mumbai: Galactus Funware Technology, the parent company of online gaming platform MPL (Mobile Premier League), has issued a legal notice to the Advertising Standards Council of India (ASCI), demanding the immediate withdrawal of a whitepaper titled 'Examining Opinion Trading in India' and seeking ₹50 crore in damages for alleged defamation and loss of goodwill.The legal notice, dated May 23, 2025, sent through their legal counsel Trilegal, accuses ASCI of publishing a "biased and unsubstantiated" whitepaper that relies on "tampered" versions of MPL's advertisements and misrepresents their content to mislead consumers.Edited screenshotsGalactus Funware claims that the ASCI whitepaper, published in May 2025, deliberately edited screenshots of their advertisements to support a "baseless conclusion" that opinion trading involves an "element of risk" and "chances of financial losses".The notice highlights specific instances of al...
Comments
Post a Comment